Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Non-alcoholic Steatohepatitis (NASH) Cirrhosis: Twenty-Two Years Data from the Scientific Registry of Transplant Recipients (SRTR)

被引:0
|
作者
Younossi, Zobair M. [1 ,4 ]
Stepanova, Maria [2 ]
Locklear, Cameron T. [1 ]
Jacobson, Ira [3 ]
Mishra, Alita [1 ]
Trimble, Gregory [1 ]
Erario, Madeline [1 ]
Venkatesan, Chapy [1 ]
Younossi, Issah [2 ]
Arsalla, Aimal [4 ]
Keo, Wisna'odom [4 ]
Goodman, Zachary D. [1 ]
机构
[1] Inova Fairfax Hosp, Dept Med, Ctr Liver Dis, Falls Church, VA USA
[2] Ctr Outcomes Res Liver Dis, Washington Dc, DC USA
[3] Med Mt Sinai Beth Israel, New York, NY USA
[4] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1682
引用
收藏
页码:899A / 900A
页数:2
相关论文
共 31 条
  • [21] PRIMARY CARE (PC) UTILIZATION, PREVENTATIVE SCREENING, AND CONTROL OF METABOLIC SYNDROME (METS) IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) LIVER TRANSPLANT (LT) RECIPIENTS
    Flynn, Sarah
    Brandman, Danielle
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S47 - S47
  • [22] CLINICAL AND PATIENT-REPORTED OUTCOMES DATA FOR PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) ACROSS THE WORLD: DATA FROM THE GLOBAL NASH REGISTRY
    Younossi, Zobair M.
    Yu, Ming-Lung
    El Kassas, Mohamed
    Esmat, Gamal
    Yilmaz, Yusuf
    Fernandez, Marlen Castellanos
    Duseja, Ajay K.
    Isakov, Vasily A.
    Buti, Maria
    Mendez-Sanchez, Nahum
    Papatheodoridis, George V.
    Chan, Wah Kheong
    George, Jacob
    Bugianesi, Elisabetta
    Romero-Gomez, Manuel
    Roberts, Stuart K.
    Younes, Ziad
    Wong, Vincent Wai-Sun
    Fan, Jian-Gao
    Eguchi, Yuichiro
    Gordon, Stuart C.
    Ahmed, Aijaz
    Ong, Janus
    Jacobson, Ira M.
    Rinella, Mary E.
    Hamid, Saeed S.
    Ziayee, Mariam
    Younossi, Issah
    Lam, Brian P.
    Arrese, Marco
    Nader, Fatema
    Racila, Andrei
    Henry, Linda
    Stepanova, Maria
    HEPATOLOGY, 2019, 70 : 749A - 750A
  • [23] Liver Transplant (LT) Candidates with Primary Biliary Cholangitis (PBC) Experience Higher Wait List Mortality: Data from the Scientific Registry of Transplant Recipients (SRTR)
    Younossi, Zobair M.
    Stepanova, Maria
    de Avila, Leyla
    Ahmed, Aijaz
    Wong, Robert J.
    Saab, Sammy
    Kowdley, Kris V.
    Brown, Kimberly A.
    Kugelmas, Marcelo
    Racila, Andrei
    HEPATOLOGY, 2017, 66 : 176A - 177A
  • [24] PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND COMPENSATED CIRRHOSIS (CC): DATA FROM THE STELLAR-4 PHASE 3 CLINICAL TRIAL
    Younossi, Zobair M.
    Stepanova, Maria
    Nader, Fatema
    Romero-Gomez, Manuel
    Okanoue, Takeshi
    Trauner, Michael H.
    Myers, Robert P.
    Djedjos, Stephen
    Harrison, Stephen A.
    Goodman, Zachary D.
    HEPATOLOGY, 2019, 70 : 1119A - 1120A
  • [25] Substantial comorbidities and rising economic burden in real-world non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) patients with compensated cirrhosis (CC): A large German claims database study
    Canbay, A.
    Meise, D.
    Haas, J. S.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S32 - S32
  • [26] PREVALENCE OF ESOPHAGEAL AND GASTRIC VARICES IN PATIENTS WITH COMPENSATED NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS AND PORTAL HYPERTENSION. DATA FROM THE ONGOING NAVIGATE STUDY
    Boudes, Pol
    Alkhouri, Naim
    De Guevara, Laura Ladron
    Elgouhari, Hesham M.
    Mena, Edward
    Ortiz-Lasanta, Grisell
    Lawitz, Eric J.
    Moore, Ann C.
    Borg, Brian
    Noureddin, Mazen
    Lucas, Kathryn Jean
    Vuppalanchi, Raj
    Reiss, Gary M.
    Schiefke, Ingolf
    Safadi, Rifaat
    Shiffman, Mitchell L.
    Behari, Jaideep
    Patel, Chirag
    Ben-Ari, Ziv
    Halegoua-De Marzio, Dina
    Patel, Pankaj
    Patel, Bhaktasharan
    Caldwell, Stephen
    Ghalib, Reem
    Kayali, Zeid
    Vierling, John M.
    Williams, Alonzo
    Aazami, Hessam
    Mills-Wison, Marla
    HEPATOLOGY, 2022, 76 : S618 - S619
  • [27] Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients
    Stepanova, Maria
    Kabbara, Khaled
    Mohess, Denise
    Verma, Manisha
    Roche-Green, Alva
    AlQahtani, Saleh
    Ong, Janus
    Burra, Patrizia
    Younossi, Zobair M.
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (07) : 1506 - 1515
  • [28] Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/Non-Alcoholic Fatty Liver Disease (NAFLD) Registry
    Younossi, Zobair M.
    Yilmaz, Yusuf
    Yu, Ming-Lung
    Wong, Vincent Wai-Sun
    Fernandez, Marlen Castellanos
    Isakov, Vasily A.
    Duseja, Ajay K.
    Mendez-Sanchez, Nahum
    Eguchi, Yuichiro
    Bugianesi, Elisabetta
    Burra, Patrizia
    George, Jacob
    Fan, Jian-Gao
    Papatheodoridis, George, V
    Chan, Wah Kheong
    Alswat, Khalid
    Saeed, Hamid S.
    Singal, Ashwani K.
    Romero-Gomez, Manuel
    Gordon, Stuart C.
    Roberts, Stuart K.
    El Kassas, Mohamed
    Kugelmas, Marcelo
    Ong, Janus P.
    Alqahtani, Saleh
    Ziayee, Mariam
    Lam, Brian
    Younossi, Issah
    Racila, Andrei
    Henry, Linda
    Stepanova, Maria
    Council, Global Nash
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (10) : 2296 - 2306
  • [29] NIACIN REGRESSES FIBROSIS IN CULTURED HUMAN HEPATIC STELLATE CELLS FROM NON-ALCOHOLIC STEATOHEPATITIS (NASH-FIBROSIS) LIVERS: POTENTIAL TREATMENT FOR LIVER CIRRHOSIS
    Ganji, Shobha H.
    Hoa, Neil
    Kamanna, Jayant
    Kamanna, Vaijinath S.
    Kashyap, Moti L.
    HEPATOLOGY, 2021, 74 : 826A - 826A
  • [30] Bile Acid and Steroid Transporter OSTα/β is Over-Expressed in Liver from Patients With Non-alcoholic Steatohepatitis (NASH) and Primary Biliary Cirrhosis (PBC), and Modulated by Drugs Using a Novel In Vitro Cell System
    Malinen, Melina
    Beaudoin, James
    Ali, Izna
    Brouwer, Kim L.
    HEPATOLOGY, 2017, 66 : 1089A - 1089A